Transcatheter Arterial Embolization for Elbow and Foot Plantar Pain
CompletedNot applicableNCT06523114
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a prospective single arm study in which patients with moderate to severe chronic elbow or foot plantar pain, in the setting of lateral epicondylitis or plantar fascitis refractory to conservative treatment, will be enrolled. The primary aim of this study is to estimate the effectiveness and safety of transcatheter arterial embolization (TAE) for changes in elbow or plantar pain with 6 and 12-month follow-up.
Study details
- Official title
- Transcatheter Arterial Embolization for Relief of Chronic Musculoskeletal Elbow and Foot Plantar Pain Refractory to Conservative Treatment
- Conditions
- Elbow Tendinitis
- Elbow Tendinopathy
- Epicondylitis of the Elbow
- Epicondylitis, Lateral
- Plantar Fascitis
- Embolization
- Interventions
- Device: Transcatheter Arterial Embolization
- Sponsor
- Chung-Ang University Hospital
- Collaborators
- Dongkook Pharmaceutical Co., Ltd.
- Start date
- 2022-04-18
- Primary completion
- 2025-09-02
- Sex
- All
- Age range
- from 19 Years to 85 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients who voluntarily signed a written consent form after receiving an explanation of the purpose, method, and effects of this clinical trial * Patients who have had pain in the relevant area for more than 6 months and have a history of receiving physical therapy, analgesic anti-inflammatory medication, or local injection treatment * Patients in whom hypervascularization was confirmed in the relevant area through imaging results (US, CT, MRI) evaluating the cause of pain. Exclusion Criteria: * Patients are pregnant or breastfeeding * Local infection in the painful area * Patients have a bleeding disease
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06523114